In a recent study investigating CRCs associated with inflammatory bowel diseases (either Crohn’s disease or ulcerative colitis), the authors found that only 43% of colitis-associated carcinomas expressed SATB2, compared to 91% sporadic CRCs [33]. The gene discussed is SATB2; the disease is ulcerative colitis.